Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion type Assertion NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_head.
- NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion description "[during the acute phase of stroke/transient ischemic attack, individuals with the AG/GG genotype had significantly elevated CRP concentrations as opposed to those with the AA genotype (2.02 +/- 1.59 vs.1.73 +/- 1.69 mg/l, P = 0.027)]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_provenance.
- NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion evidence source_evidence_literature NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_provenance.
- NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion SIO_000772 17355554 NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_provenance.
- NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion wasDerivedFrom lhgdn-20090331 NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_provenance.
- NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_assertion wasGeneratedBy ECO_0000203 NP211797.RAgcErBflJKMbr2_KyKB005W4SLE3yhyrjUjdHQ3EQLPQ130_provenance.